|
Amersham™ ECL™ detection systems |
Amersham ECL Western Blotting Systems from GE Healthcare have been delivering sensitivity, speed, and versatility since 1990. Today, the world’s first chemiluminescent reagents continue to be the most widely used and have established a well-earned reputation for excellence you can rely on, day in, day out.
Amersham ECL, Amersham ECL Plus, and Amersham ECL Advance™ are now complemented by the Amersham ECL Plex™ fluorescent system, expanding your options even further. ECL Plex brings multiplex detection to Western blotting, enabling a faster detection process, normalization to internal loading standards for better quantitation, and accurate comparison of protein targets without the need to strip and reprobe the membrane.
1990
Amersham ECL makes nonradioactive protein detection possible for the first time
1997
Amersham ECL Plus introduces flexible chemiluminescent and chemifluorescent detection for Western blotting
| |
2002
Amersham ECL Advance dramatically decreases primary antibody consumption, enabling efficient use of expensive or scarce reagents
2005
Amersham ECL Plex brings multiplex, quantitative fluorescent analysis to 1-D and 2-D gels, enabling faster detection and better resolution of protein targets with identical moelcular weights. |
|
